146 related articles for article (PubMed ID: 33414085)
1. High-dose pre-endoscopic intravenous proton pump inhibitors in upper gastrointestinal bleeding: Utility or futility?
Primignani M; Tosetti G
Dig Liver Dis; 2021 Mar; 53(3):387-388. PubMed ID: 33414085
[No Abstract] [Full Text] [Related]
2. Reply to: High-dose pre-endoscopic intravenous proton pump inhibitors in upper gastrointestinal bleeding: utility or futility?
Marmo R; Soncini M; Bucci C; Zullo A
Dig Liver Dis; 2021 Mar; 53(3):389. PubMed ID: 33472768
[No Abstract] [Full Text] [Related]
3. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
[TBL] [Abstract][Full Text] [Related]
4. The short-term medical management of non-variceal upper gastrointestinal bleeding.
Kovacs TO; Jensen DM
Drugs; 2008; 68(15):2105-11. PubMed ID: 18840002
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysis.
Zhang YS; Li Q; He BS; Liu R; Li ZJ
World J Gastroenterol; 2015 May; 21(20):6341-51. PubMed ID: 26034370
[TBL] [Abstract][Full Text] [Related]
6. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
Huggins RM; Scates AC; Latour JK
Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic therapy for nonvariceal upper gastrointestinal bleeding.
Wu JC; Sung JJ
Gastrointest Endosc Clin N Am; 2011 Oct; 21(4):671-9. PubMed ID: 21944417
[TBL] [Abstract][Full Text] [Related]
8. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease.
Miyake K; Akimoto T; Hanada Y; Nagoya H; Kodaka Y; Ueki N; Kusunoki M; Kawagoe T; Futagami S; Takahashi Y; Takano H; Sakamoto C
Dig Liver Dis; 2015 Sep; 47(9):757-62. PubMed ID: 26105589
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.
Green DS; Abdel-Latif ME; Jones LJ; Lui K; Osborn DA
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011785. PubMed ID: 31265739
[TBL] [Abstract][Full Text] [Related]
11. The role of proton pump inhibitors in the management of upper gastrointestinal bleeding.
Leontiadis GI; Howden CW
Gastroenterol Clin North Am; 2009 Jun; 38(2):199-213. PubMed ID: 19446254
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors, histamine-2 receptor antagonists, gastroprotection and lower gastrointestinal tract bleeding in low-dose aspirin users.
Fernández-Fernández FJ; Ameneiros-Lago E; Sesma P; Pía G
Dig Liver Dis; 2016 Feb; 48(2):211. PubMed ID: 26699825
[No Abstract] [Full Text] [Related]
14. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K
Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833
[TBL] [Abstract][Full Text] [Related]
15. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Niro V; Longo MG; D'Ambrosio LP; Andriulli A; Di Mario F
Aging Clin Exp Res; 2003 Dec; 15(6):494-9. PubMed ID: 14959953
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of stress induced ulcers: histamine-2 receptor antagonists or proton pump inhibitors? - gastric hemorrhage occur more often under proton pump inhibitors].
Tank S; Kerner T
Dtsch Med Wochenschr; 2014 Jun; 139(25-26):1338. PubMed ID: 24914510
[No Abstract] [Full Text] [Related]
17. Critical review of acid suppression in nonvariceal, acute, uppergastrointestinal bleeding.
Yacyshyn BR; Thomson AB
Dig Dis; 2000; 18(3):117-28. PubMed ID: 11279330
[TBL] [Abstract][Full Text] [Related]
18. [Recent progress in the drug therapy for gastrointestinal bleeding].
Nakajima S; Bamba T
Nihon Rinsho; 1998 Sep; 56(9):2291-6. PubMed ID: 9780708
[TBL] [Abstract][Full Text] [Related]
19. Drugs for pH control in upper gastrointestinal bleeding.
Brunner G; Luna P; Thiesemann C
Aliment Pharmacol Ther; 1995; 9 Suppl 1():47-50. PubMed ID: 7495943
[TBL] [Abstract][Full Text] [Related]
20. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]